A study by Gan et al. has demonstrated that higher serum levels of IL-17A, and especially higher levels of IL-17F, are associated with higher autoantibody (including ANA) levels in patients with primary Sjögren’s syndrome. This evidence concerns the gene IL17A and Sjogren syndrome.